PROTHENA CORPORATION PUBLIC LIMITED COMPANY Lessee, Operating Lease, Liability, to be Paid, Year One
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Lessee, Operating Lease, Liability, to be Paid, Year One of $3.31 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $3.31M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $3.27M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $3.30M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $3.30M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $3.31M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $3.27M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $3.30M 10-K · filed 2026-02-27 |
| 2025-09-30 | $3.30M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $3.30M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $3.16M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $3.18M 10-K · filed 2025-02-27 |
| 2024-09-30 | $3.19M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $3.18M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.05M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.83M 10-K · filed 2024-02-22 |
| 2023-09-30 | $2.83M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.83M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $2.71M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $6.62M 10-K · filed 2023-02-28 |
| 2022-09-30 | $6.62M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $6.62M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $6.54M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.42M 10-K · filed 2022-02-25 |
| 2021-09-30 | $6.42M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $6.42M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.35M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $6.19M 10-K · filed 2021-02-26 |
| 2019-12-31 | $6.00M 10-K · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |